retatrutide safety trial results First phase 3 data, a Triumph of Science! Tirzepatide vs. Retatrutide: Key Differences

A limitation of the current review is that it focused on indirect comparisons of 24-h continuous monitoring studies that differed in terms of study population (e.g., obese or not-obese, ambulatory or not-ambulatory), study treatment (e.g., continuous intravenous infusion, or oral administration) and timing of assessment after variable duration of study treatment

Public Health 17 , 4690 (2020)

The peptide dosing guide provides detailed instructions for managing multi-compound protocols, and the cycling guide covers how to structure on and off periods

Self-directed microdosing usually has none of that

To, K., Cao, R., Yegiazaryan, A., Owens, J., Nguyen, T., Sasaninia, K., Venketaraman, V